Invasive nosocomial pulmonary aspergillosis;Aspergilloses pulmonaires invasives d'origine nosocomiale

Revue de Pneumologie Clinique

Volumn 57, Issue 2, 2001, Pages 157-163

  Germaud, P ^a   Haloun, A ^a  

^a CHU de Nantes   (France)

Author keywords

Aspergillus; Invasive pulmonary aspergillosis; Nosocomial infection; Tracheobronchial aspergillosis

Indexed keywords

BONE MARROW TRANSPLANTATION; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; LUNG ASPERGILLOSIS; MORTALITY; NEUTROPENIA; PROGNOSIS; REVIEW; RISK FACTOR;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CROSS INFECTION; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION CONTROL; LUNG DISEASES, FUNGAL; NEUTROPENIA; PROGNOSIS; RISK FACTORS;

EID: 0035041524     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Bartlett J. G. : Aspergillosis update. Medicine, 2000, 79, 281-2.
2. Young R. C., Bennett J. E., Vogel C. L., Carbone P. P., DeVita V. T. : Aspergillosis : the spectrum of the disease in 98 patients. Medicine, 1970, 49, 147-73.
3. Delarue J., Diebold J., Nouzy G. : Aspects anatomopathologiques des aspergilloses compliquant les leucémies. Arch. Anat. Path., 1971, 19, 135-45.
4. Denning D. W. : Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis., 1996, 23, 608-15.
5. Patterson T. F., Kirkpatrick W. R., White M., Hiemenz J. W., Wingard J. R., Dupont B., Rinaldi M. G., Stevens D. A., Graybill J. R., for the Aspergillus study group : Invasive aspergillosis disease spetrum, treatment practice, and outcomes. Medicine, 2000, 79, 250-60.
6. Conférence de consensus : Prévention du risque aspergillaire chez les patients immunodéprimés (hématologie, transplantation). La lettre de l'infectiologue, 2000, 15, 416-22.
7. Morin O., Germaud P. : Asperaillose pulmonaire et immunodépression. Rev. fr lab., 1991, 223, 27-38.
8. Nolard N : Les liens entre les risques d'aspergillose et la contamination de l'environnement : revue de la littérature. Pathol. Biol., 1994,42, 706-10.
9. Aisner J., Schimpf S. C., Bennet J. E., Young V. M., Wiernik P. H. : Aspergillus infections in cancer patients : association with fireproofing materials in a new hospital. JAMA, 1976, 235, 411-2.
10. Arnow P. M., Andersen R. L., Mainous P. D., Smith E. J. : Pulmonary aspergillosis during hospital renovation. Am. Rev. Respir. Dis., 1978, 118, 49-53.
11. Schwartz T. Z., Behr G., Heinemann V. : Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia : results of a prospective randomized multicenter trial. Blood, 1999, 11, 3654-64.
12. Paterson D. L . Singh N. : Invasive aspersillosis in transplant recipients. Medicine, 1999, 78, 123-38.
13. Gerson S. L., Talbot G. H., Hurwitz S : Prolonged granulocytopenia : the major risk factor for invasive pulmonary aspergillosis in patients withn acute leukemia. Ann. Intern. Med., 1984, 100. 354-51.
14. Chugh K. S., Sakhuja V., Jain S., Singh V., Tarafdar A., Joshi K., Gupta K. L., Minz M. : Fungal infection in renal allograft recipients. Transplant Proc., 1992, 24, 1940-2.
15. Denning D. W. : Invasive aspergillosis. Clin. Infec. Dis., 1998, 26, 781-805.
16. Mylonakis E., Barlam T F., Flanigan T., Rich J. D : Pulmonary aspergillosis and invasive disease in AIDS. Chest., 1998, 114, 251-62.
17. Rello J., Esandi M. E., Mariscal D., Gallego M., Domingo C. H., Valles J. : Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease : report of eight cases and review. Clin. Infect. Dis., 1998, 26, 1473-5.
18. Ordronneau J., De Lajartre A. Y., Chollet S., Germaud P., Moinard D., Chailleux E. : Aspergillose invasive disséminée associée à une infection à Mycoplasma pneumoniae. Rev. Mal. Resp., 1987, 4, 273-5.
19. Meeker D. P., Gephardt G. N., Cordasco E. M. : Hypersensitivity pneumonitis versus invasive pulmonary aspergillosis : two cases with unusual pathologic findings and review of literature. Am. Rev. Resp. Dis., 1991, 143, 431-6.
20. Latgé J. P. :Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev., 1999, 12, 310-50.
21. Bocquet B., Patris S., Dumartin C., Gottot S., Rykner G., Brucker G. : Le réseau de surveillance épidémiologique de l'aspergillose pulmonaire invasive nosocomiale de l'assistance publique-hôpitaux de Paris. Ann. Med. Interne., 1995, 146, 79-83.
22. De Bock R., Gyssens I., Peetermans M., Nolard N. : Aspergillus in pepper. Lancet, 1989, 8658, 331-2.
23. Germaud P., Buhe Th., De Lajartre A. Y. : Le poumon aspergillaire : aspects radiologiques. Ann. Med. Interne., 1995, 146, 91-5.
24. Stevens D. A., Lee J. Y. : Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mucoses Study Group criteria. Arch. Intern. Med., 1997, 157, 1857-62.
25. Kramer M. R., Denning D. W., Marshall S. E., Ross D. J., Berry G.. Lewiston N. J., Stevens D. A., Theodore J : Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am. Rev Respir Dis., 1991, 144, 552-6.
26. Gallis H. A., Drew R. H., Pickard W. : Amphotericin B : 30 years of clinical experience. Rev. Infect. Dis., 1990, 12, 308-29.
27. Leenders A., Daenen S., Jansen R., et al. : Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br. J. Haematol., 1998, 103, 205-12.
28. Wingard J. R., White M. H., Anaissie E., et al. : Randomized, double-blind comparative trial evaluation the safety of liposomal amphotericine B versus amphotericine B lipid complex of the empirical treatment of febrile neutropenia. Clin. Infect. Dis., 2000, 31, 1155-63.
29. Stevens D. A., Kan V. L., Judson M. A., et al. : Practice guidelines for diseases caused by Aspergillus. Clin. Infect. Dis., 2000, 30, 696-709.
30. Caillot D., Casasnovas O., Bernard A., Couailler J. F., Durand C., Cuisenier B., Solary E., Piard F., Petrella T., Bonnin A., Couillault G., Dumas M., Guy H. : Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J. Clin. Oncol., 1997, 15, 139-47.
31. Baron O., Guillaume B., Moreau P., Germaud P., Despins P., De Lajartre A. Y., Michaud J. L. : Aggressive surgical management in localized pulmonary mycotic and non mycotic infections for neutropenic patients with acute leukemia : report of eighteen cases. J. Thorac. Cardiovasc. Surg., 1998, 115, 63-9.
32. Denning D. W., Stevens D. A. : Antifungal and surgical treatment of invasive aspergillosis : of 2.121 published cases. Rev. Infect. Dis., 1990, 12, 1147-201.
33. Erjavec Z., Woolthuis G. M. H., de Vries-Hospers H. G., Sluiter W. J., Daenen SMG. J., de Pauw B., Halie M. R. : Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. Eur. J. Clin. Microbiol. Infect. Dis., 1997, 16, 364-8.
34. Perfect J. R., Klotman M. E., Gilbert C. C., Crawford D. D., Rosner G. L., Wright K. A., Peters W. P. : Prophylactic intravenous amphotencin B in neutropenic autologous bone marrow transplant recipients. J. Infect. Dis., 1992, 165, 891-7.
35. Beyer J., Schwartz S., Heinemann V., Siegert W. : Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrob. Agents Chemoter., 1994, 38, 911-7.
36. Tollemar J. K., Ringden O., Andersson S., Sundberg B , Ljungman P., Tyden G. : Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplant, 1993, 12, 577-82.
37. Thunnissen P. L. M., Sizoo W., Hendriks W. D. H. : Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients. Neth. J. Med., 1991, 39, 84-91.
38. Harousseau J. L., Dekker A. W., Stamatoullas-Bastard A., et al. : Itraconazole oral solution for primay prophylaxis of fungal infections in patients with hematological malignancy and profond neutropenia : a randomized, double blind, double placebo, multicenter trial comparing itraconazole and amphotericin B capsules. Antimicrob. Agents Chemother., 2000, 44, 1887-93.